Business

Recently, a federal judge in New Jersey made a significant ruling regarding Johnson & Johnson’s and Bristol Myers Squibb’s legal challenges to the Biden administration’s Medicare drug-price negotiations. The judge rejected their claims, stating that the program is constitutional. This decision marks a victory for the White House in its ongoing legal dispute with multiple
The Food and Drug Administration recently approved Pfizer’s gene therapy treatment for hemophilia B, marking a significant milestone for the company. This groundbreaking approval opens up new possibilities for patients suffering from this rare genetic bleeding disorder. However, as we delve deeper into the details of this approval, it is crucial to critically analyze the
Walgreens is taking a significant step by working directly with drugmakers to bring cell and gene therapies to U.S. patients. This move is part of a broader expansion of its specialty pharmacy services. The company is venturing into a new business unit dedicated to its specialty pharmacy segment, which includes the specialty pharmacy subsidiary AllianceRx.
PepsiCo recently released its quarterly earnings report, revealing results that exceeded analysts’ expectations. Despite facing challenges such as weaker U.S. demand and recalls of Quaker Oats products, the company managed to achieve positive results. In terms of earnings per share, PepsiCo reported $1.61 adjusted, surpassing the expected $1.52. Revenue also exceeded expectations, coming in at
In the real estate market, there is a notable trend emerging – a clear division between the luxury sector and the rest of the market. While overall real estate sales have seen a decline of 4% nationwide in the first quarter, luxury real estate sales have actually increased by more than 2%, marking their best